|
Volumn 97, Issue 2, 2002, Pages 111-112
|
Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ATRIAL NATRIURETIC FACTOR;
BRAIN NATRIURETIC PEPTIDE;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
LOSARTAN;
NEUROHORMONE;
RENIN;
STEROID;
ADULT;
AGED;
CHRONIC RESPIRATORY FAILURE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
COUGHING;
DISEASE CLASSIFICATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG TOLERABILITY;
FEMALE;
HEART RIGHT VENTRICLE OVERLOAD;
HOME CARE;
HORMONE BLOOD LEVEL;
HORMONE DETERMINATION;
HUMAN;
HYPOXEMIA;
LETTER;
LUNG DISEASE;
MALE;
MORTALITY;
OXYGEN THERAPY;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN ANALYSIS;
PROTEIN BLOOD LEVEL;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
AGED;
AGED, 80 AND OVER;
ANTI-ARRHYTHMIA AGENTS;
ATRIAL NATRIURETIC FACTOR;
FEMALE;
HUMANS;
LOSARTAN;
LUNG DISEASES, OBSTRUCTIVE;
MALE;
MIDDLE AGED;
NATRIURETIC PEPTIDE, BRAIN;
|
EID: 0036238947
PISSN: 00086312
EISSN: None
Source Type: Journal
DOI: 10.1159/000057682 Document Type: Letter |
Times cited : (2)
|
References (18)
|